SUMO1 anticorps

N° du produit ABIN1882054

Détail du produit anti-SUMO1 anticorps

Antigène: SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp SUMO1 est non-conjugé

Application: Western Blotting (WB)

Purification: This antibody is purified through a protein G column, followed by dialysis against PBS.

Immunogène: Purified recombinant GST-SUMO1 protein was used as immunogen.

Clone: 66AT1320

Isotype: IgG1

Information d'application

Indications d'application: WB: 1:100~500

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified monoclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Date de péremption: 6 months

Références pour anticorps anti-SUMO1 (ABIN1882054)

Li, Perkins, Su, Ma, Colson, Horne, Chen: "Gold nanoparticles as a platform for creating a multivalent poly-SUMO chain inhibitor that also augments ionizing radiation." dans: Proceedings of the National Academy of Sciences of the United States of America, Vol. 109, Issue 11, pp. 4092-7, (2012) (PubMed).

Truong, Su, Song, Chen: "Entropy-driven mechanism of an E3 ligase." dans: Biochemistry, Vol. 50, Issue 25, pp. 5757-66, (2011) (PubMed).

Jia, Li, Meng, Shi: "Association between polymorphisms at small ubiquitin-like modifier 1 and nonsyndromic orofacial clefts in Western China." dans: DNA and cell biology, Vol. 29, Issue 11, pp. 675-80, (2010) (PubMed).

Mostowska, Hozyasz, Wojcicki, Biedziak, Paradowska, Jagodzinski: "Association between genetic variants of reported candidate genes or regions and risk of cleft lip with or without cleft palate in the polish population." dans: Birth defects research. Part A, Clinical and molecular teratology, Vol. 88, Issue 7, pp. 538-45, (2010) (PubMed).

Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: "Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study." dans: Diabetes Care, Vol. 33, Issue 10, pp. 2250-3, (2010) (PubMed).

Jugessur, Shi, Gjessing, Lie, Wilcox, Weinberg, Christensen, Boyles, Daack-Hirsch, Nguyen, Christiansen, Lidral, Murray: "Maternal genes and facial clefts in offspring: a comprehensive search for genetic associations in two population-based cleft studies from Scandinavia." dans: PLoS ONE, Vol. 5, Issue 7, pp. e11493, (2010) (PubMed).

Song, Wang, Jozwiak, Hu, Swiderski, Chen: "Stability of thioester intermediates in ubiquitin-like modifications." dans: Protein science : a publication of the Protein Society, Vol. 18, Issue 12, pp. 2492-9, (2009) (PubMed).

Shanwell, Ringdén, Wiechel, Rumin, Akerblom: "A study of the effect of ABO incompatible plasma in platelet concentrates transfused to bone marrow transplant recipients." dans: Vox sanguinis, Vol. 60, Issue 1, pp. 23-7, (1991) (PubMed).

Détails sur SUMO1

Antigène: SUMO1 (Small Ubiquitin Related Modifier Protein 1 (SUMO1))

Autre désignation: SUMO1 (SUMO1 Produits)

Synonymes: anticorps DAP1, anticorps GMP1, anticorps OFC10, anticorps PIC1, anticorps SENP2, anticorps SMT3, anticorps SMT3C, anticorps SMT3H3, anticorps UBL1, anticorps hm:zeh0670, anticorps wu:fb74c02, anticorps wu:fd12c02, anticorps zgc:65934, anticorps zgc:85634, anticorps SUMO1, anticorps dap1, anticorps gmp1, anticorps ofc10, anticorps pic1, anticorps senp2, anticorps smt3, anticorps smt3c, anticorps sumo-1, anticorps sumo1, anticorps ubl1, anticorps xsumo-1, anticorps xsumo1, anticorps ARABIDOPSIS THALIANA SMALL UBIQUITIN-LIKE MODIFIER 1, anticorps ATSUMO1, anticorps F10M23.180, anticorps F10M23_180, anticorps SMALL UBIQUITIN-LIKE MODIFIER 1, anticorps SUM1, anticorps SUMO 1, anticorps small ubiquitin-like modifier 1, anticorps pigSUMO1, anticorps SENTRIN, anticorps SMTP3, anticorps SUMO-1, anticorps Smt3C, anticorps Ubl1, anticorps small ubiquitin-like modifier 1, anticorps small ubiquitin-like modifier 1 S homeolog, anticorps small ubiquitin-related protein 1, anticorps SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae), anticorps SMT3 suppressor of mif two 3 homolog 1 (yeast), anticorps small ubiquitin-like modifier 1 L homeolog, anticorps Sumo1, anticorps SUMO1, anticorps sumo1, anticorps sumo1.S, anticorps sumo-1, anticorps sumo1.L

Sujet: This gene encodes a protein that is a member of the SUMO (small ubiquitin-like modifier) protein family. It functions in a manner similar to ubiquitin in that it is bound to target proteins as part of a post-translational modification system. However, unlike ubiquitin which targets proteins for degradation, this protein is involved in a variety of cellular processes, such as nuclear transport, transcriptional regulation, apoptosis, and protein stability. It is not active until the last four amino acids of the carboxy-terminus have been cleaved off. Several pseudogenes have been reported for this gene. Alternate transcriptional splice variants encoding different isoforms have been characterized.

Poids moléculaire: 11557

NCBI Accession: NP_001005781, NP_001005782, NP_003343

UniProt: P63165

Pathways: M Phase, Positive Regulation of Endopeptidase Activity, Protein targeting to Nucleus, Ubiquitin Proteasome Pathway